Advertisements

Tussilene

Quick links to important sections

Tussilene

Selected form

Advertisements
Advertisements

Treatment option: Cough

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Tussilene

Quick Facts: Tussilene Overview

Property Description
Active Ingredient Dextromethorphan Hydrobromide (DXM)
Pharmacological Class Antitussive (Cough Suppressant)
Common Forms Oral Solution, Syrup, Tablet
Route of Administration Oral (by mouth)
Origin / Type Synthetic Morphinan Derivative

What Type of Medicine is Tussilene?

Tussilene is classified as an antitussive, a specific type of medicine whose function is to serve as a cough suppressant. Its therapeutic component is the single active ingredient, Dextromethorphan Hydrobromide (DXM). Dextromethorphan is identified as a synthetic compound and a morphinan derivative; however, it functions as a non-opioid agent, dedicated solely to cough relief without the classic analgesic effects. Its efficacy as an antitussive is recognized for symptomatic management. Dextromethorphan is an established over-the-counter antitussive, utilized for its role in managing cough symptoms.


Composition and General Purpose of Tussilene

Tussilene's composition is focused solely on the single active substance, Dextromethorphan Hydrobromide, distinguishing it as a monotherapy for cough, unlike combination remedies. Tussilene is commonly available as an oral solution or syrup, a liquid preparation taken orally and suspended in an aqueous liquid base. This liquid format is often preferred for ease of administration across various age groups, representing a practical formulation differentiation. The general purpose of Tussilene is to provide symptomatic relief of cough by intervening directly with the nerve signals in the brain that trigger the reflex. This action is intended for managing the frequent and irritating non-productive cough (dry cough), offering a systemic way to reduce the intensity of coughing fits.

Advertisements

What side effects are possible with Tussilene?

Possible side effects and safety information

Official regulatory documents classify adverse reactions to Tussilene (Dextromethorphan) primarily within the Nervous System and Gastrointestinal System domains.


Frequency Classification System-Organ Classes Involved
Common (e.g., ge 1/100 users) Drowsiness, Dizziness, Nausea, Vomiting, Constipation
Uncommon (e.g., ge 1/1,000 users) Skin Rash, Restlessness, Mental Confusion
Frequency Not Known Hypersensitivity Reactions, Serotonin Syndrome, Abuse Potential

Serious Adverse Reactions and Restrictions

Label-documented safety concerns include the risk of Serotonin Syndrome, a potentially life-threatening condition associated with excessive serotonin activity, particularly when Tussilene is taken with other serotonergic medications like Monoamine Oxidase Inhibitors (MAOIs). For this reason, official labeling strictly contraindicates Tussilene use concurrently with MAOIs or within 14 days of discontinuing MAOI treatment.

Furthermore, regulatory documents note the potential for Drug Dependence and Abuse with prolonged high-dose use. Safety cautions are also specified for individuals with severe hepatic impairment due to the drug’s metabolism in the liver, which may increase the risk of toxicity.


Connection to the Overall Safety Profile

This structure establishes a clear distinction between common, expected effects (such as drowsiness, which may be more pronounced at the start of treatment) and rare, serious concerns (such as Serotonin Syndrome). The inclusion of explicit contraindications and special population warnings defines the boundaries of use, based entirely on the risk profile documented by official health authorities.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The information in this section describes the officially documented clinical manifestations and emergency requirements for Tussilene (Dextromethorphan) overdose, based strictly on government regulatory documents.

Documented Overdose Presentations
Neurological and Autonomic Manifestations: Symptoms may include mental confusion, hallucinations, dizziness, unsteady walking (ataxia), involuntary eye movements (nystagmus), muscle twitches, high body temperature (hyperthermia), and rapid heartbeat (tachycardia).
Severe Outcomes: Life-threatening reactions officially documented are Serotonin Syndrome, seizures, and severe respiratory depression which can progress to coma.
Emergency Action and Risk Notes
When to Seek Immediate Help: The official regulatory stance mandates that immediate medical attention must be sought for all suspected overdoses. Contact emergency services or a poison control center immediately.
Population-Specific Overdose Notes: Overdose risk is documented to be higher in individuals who are CYP2D6 poor metabolizers or who co-ingest other serotonergic agents.

Official Overdose Statements on Management:

  • Management requires symptomatic and supportive treatment and continuous monitoring of vital signs in a hospital setting.
  • Interventions may include administration of activated charcoal and the use of Naloxone to address severe CNS and respiratory depression.
  • The presence of multiple or escalating symptoms necessitates immediate professional intervention.
Advertisements

Therapeutic Uses of Tussilene

What Tussilene Treats: Main Uses and Benefits

Tussilene (Dextromethorphan) is commonly used to help with symptomatic relief by supporting the management of the cough reflex. Its therapeutic focus is applied in addressing the symptoms related to heightened physiological activity, offering supportive relief across acute therapeutic contexts. The medication is generally used to temporarily relieve cough associated with conditions presenting with acute episodes such as the common cold, the flu, or other irritative states.

The medication may be part of symptomatic management for the frequent, irritating, non-productive cough (dry cough). It is used for managing symptom clusters that may appear suddenly, and may assist with easing the noticeable functional strain caused by heightened physiological activity. Used in areas where short-term symptom management is appropriate, Tussilene is applicable within clinical settings that involve acute or disruptive symptom patterns, particularly when the cough interferes with daily comfort and rest. This offers symptomatic relief that helps patients cope more steadily with symptom fluctuations and contributes to easing the overall symptom load.


Quick Fact: Relief for Dry Cough
Relevant Symptom Irritating, non-productive cough
Key Benefit Contributes to easing the overall symptom load
Clinical Context Symptoms that interfere with daily functioning (e.g., rest/sleep)

Regulatory References

  1. NIH MedlinePlus overview on Dextromethorphan
Advertisements

Eligibility and Restrictions for Use

The eligibility for Tussilene (Dextromethorphan) is strictly defined by regulatory guidelines, outlining populations who must not use the medicine and those requiring caution.

Contraindications (Do Not Use)

Classification Population Status
Pharmacological Taking an MAOI or within 14 days of stopping one Contraindicated
Age Threshold Children under 12 years (International) or under 4 years (US OTC) Contraindicated/Not Recommended
Medical History Known hypersensitivity to the formulation Contraindicated
Physiological State At risk of respiratory failure (e.g., severe asthma, pneumonia) Contraindicated

Conditional Use and Restrictions

  • Chronic Conditions: Not recommended for a chronic cough (e.g., associated with smoking or emphysema) or a cough producing excessive secretions (phlegm), unless directed by a clinician.
  • Organ Function: Caution should be exercised in patients with hepatic impairment (liver dysfunction) or severe renal impairment (kidney dysfunction).
  • Reproductive States: Use is generally not recommended during pregnancy or lactation, as established safety data is limited and the substance is excreted in breast milk.

Official regulatory documents define who can and cannot use Tussilene by prohibiting its use in certain high-risk drug interactions (MAOIs) and specifying minimum age requirements. Conditional use warnings further limit eligibility based on pre-existing organ function or chronic respiratory conditions.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tussilene (Dextromethorphan) has officially documented interaction patterns that involve metabolic pathways and additive pharmacodynamic effects, which are strictly defined in regulatory documents.

Interaction Scope and Restrictions

The regulatory profile mandates an absolute contraindication against the concurrent use of Tussilene with Monoamine Oxidase Inhibitors (MAOIs), or within the 14 days following the discontinuation of MAOI therapy. This restriction is necessary due to the officially recognized risk of developing Serotonin Syndrome from additive effects.

Tussilene is primarily metabolized by the cytochrome P450 isoenzyme CYP2D6. Co-administration with potent CYP2D6 inhibitors (e.g., Quinidine, Fluoxetine, Paroxetine) is documented to cause a significant increase in dextromethorphan plasma concentrations (exposure), potentially leading to exaggerated effects. The co-administration of Tussilene with other serotonergic agents (e.g., SSRIs) carries a documented risk of Serotonin Syndrome.

Pharmacodynamic and Population Notes

Use with other Central Nervous System (CNS) depressants, including Alcohol (Ethanol), is documented to increase the overall CNS depressant effect, and consumption should be officially avoided or limited. Caution is required when used in patients with hepatic dysfunction due to the metabolic pathway. Additionally, individuals classified as CYP2D6 Poor Metabolizers are noted in regulatory information as being at higher risk for exaggerated and prolonged effects due to naturally increased exposure.

Advertisements

Mechanism of Action

Tussilene, containing dextromethorphan, acts primarily within the central nervous system (CNS) to modulate the cough reflex arc. The compound functions as an agonist at the sigma-1 receptor (sigma1R), a chaperone protein localized to the endoplasmic reticulum, particularly in neurons of the brainstem's medullary cough center.

Simultaneously, dextromethorphan acts as a low-affinity non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, a ligand-gated ion channel. This antagonism interferes with excitatory glutamatergic neurotransmission in the CNS. The combined molecular interactions lead to a resultant increase in the threshold for stimulating the afferent sensory nerve fibers in the respiratory tract. This intracellular consequence translates to a system-level physiological modulation: an elevation of the cough center stimulation threshold, which dampens the central processing of peripheral tussive stimuli.

Advertisements

Dosage and Administration Information

Tussilene (Dextromethorphan Hydrobromide) is administered solely via the oral route for temporary management of the cough reflex. The medication is available in several official formulations, including immediate-release (IR) liquids, solutions, and capsules, as well as extended-release (ER) oral suspensions. The appropriate dosing schedule and amount are defined to ensure correct use.


Administration Guidelines

Component Official Guidance (Adults ≥ 12 years)
Dosing Schedule IR Forms: 10 mg to 20 mg every 4 hours, OR 30 mg every 6 to 8 hours. ER Forms: 60 mg every 12 hours.
Maximum Dose Not to exceed 120 mg in any 24-hour period.
Duration of Use Intended for short-term, as-needed use. Discontinue if cough persists for more than 7 days.

The medication can be taken with or without food. However, specific administration requirements must be followed to ensure the dose accuracy and intended drug release profile. Liquid suspensions require shaking the bottle well before use, and the dose must be measured precisely using the dosing cup or device provided. Extended-release formulations must be swallowed whole; they should not be crushed, chewed, or divided, as this alters the delivery mechanism.

Age-Specific Use

The standard adult regimen applies to individuals aged 12 years and older. Tussilene is generally not recommended for children under 4 years of age. Doses for children between 6 and 12 years are reduced compared to the adult maximums.

This structured protocol defines the method, schedule, and limitations for using Tussilene.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tussilene

Evidence for Use in Acute Cough

Research into Tussilene (Dextromethorphan) was studied for acute non-productive cough, a condition associated with acute or disruptive episodes, typically linked to upper respiratory infections. The main research approach has utilized short-term Randomized Controlled Trials (RCTs) and systematic reviews that synthesize this data. Studies used an inactive substance (placebo) as a comparator in these trials. These trials are used in research exploring how symptoms change over time in the observed populations. Researchers monitored both objective measures, such as total cough count recorded over specific time intervals, and subjective measures, which are patient-reported outcomes describing perceived discomfort.

The findings describe patterns observed in the studies related to changes in both cough frequency and symptom scores over short-term observation periods. Specialized laboratory studies also explored the effect on the body's cough reflex sensitivity, which research examines as an outcome monitoring physiological strain or stress. Systematic reviews summarizing the overall evidence noted that findings were mixed when comparing results from objective cough counts against what patients themselves reported. This difference in measured outcomes contributes to the broader evidence landscape and indicates the challenge in uniformly measuring cough patterns.


Evidence in Specific Populations

Evidence was derived from studies conducted in adults. Research has explored the use of Tussilene in certain pediatric subjects, primarily those children aged 6 to 11 years with a cough from a common cold. The results apply only to the populations studied, meaning the patterns observed in these groups cannot be reliably extended to others.

Conversely, the data for certain groups remain insufficient. Specifically, evidence is limited for very young children, particularly those under four years old, where use is not fully established through systemic clinical trials.


Evidence Quality, Consistency, and Research Gaps

The body of research supporting Tussilene’s antitussive use includes Randomized Controlled Trials, placing its general Evidence level as Moderate. This rating reflects that the evidence quality varies across studies, particularly among older research. One of the main research limitation frames is the inconsistent data observed across the evidence base; the findings were mixed between different studies. Furthermore, long-term effects are not fully established.

Key Studies & References

  1. Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures
  2. Dextromethorphan Efficacy for Children's Acute Cough: Objective and self-reported evidence in children aged 6–11 years with acute cough due to the common cold
  3. Cough (acute): antimicrobial prescribing - Summary of the evidence (NICE Guideline NG120)
  4. Dextromethorphan - StatPearls - NCBI Bookshelf (NIH)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tussilene (FAQ)


Q: Is Tussilene the same kind of medicine as other cough remedies?

A: According to official product information, Tussilene (Dextromethorphan) is classified as an antitussive or cough suppressant. Its function is to work within the central nervous system to quiet the cough reflex. Unlike some combination cold remedies, Tussilene is often sold as a single-ingredient medicine and is classified as a non-opioid.


Q: Is Tussilene safe to take for long periods of time?

A: Regulatory documents state that Tussilene is only intended for short-term, as-needed use. Official guidance indicates that if a cough persists for more than seven days, the medicine should be discontinued. Studies and official information indicate that long-term effects of Tussilene have not been fully established.


Q: Are there any foods or drinks that should be avoided while using Tussilene?

A: Tussilene can be taken with or without food. Official warnings document that the consumption of alcohol must be avoided or limited due to the risk of additive central nervous system (CNS) side effects like dizziness and excessive drowsiness.


Q: Is Tussilene considered an addictive medicine?

A: Regulatory documents acknowledge the potential for Drug Dependence and Abuse when Tussilene is used at prolonged high doses. At the recommended therapeutic doses, it is classified as a non-opioid medicine. The potential for abuse and dependence is documented to be associated with prolonged, high-dose use.


Q: Can Tussilene affect your sleep patterns?

A: Official side effect lists include drowsiness as a common reaction and restlessness as an uncommon reaction. Both of these effects could interfere with a person's normal sleep patterns. Patients are generally advised to be aware of how the medicine affects them.


Q: Can Tussilene be used by older adults (e.g., over 65)?

A: Tussilene is approved for use in adults, which includes older adults. However, health authorities advise exercising caution for individuals 65 years and older, especially if they are taking multiple other central nervous system-active medicines. Regulatory information notes a requirement for caution in this population due to a potential increase in certain side effects, such as dizziness.


Q: Is Tussilene effective for a 'chest cold'?

A: Tussilene is officially indicated for the temporary relief of cough associated with the common cold. It is most beneficial for a non-productive cough, which is a dry cough. The medicine is not recommended for a cough that produces excessive phlegm or mucus.


Q: What is the meaning of the warning about 'impaired judgment' with Tussilene?

A: This safety warning is related to common side effects like drowsiness, dizziness, and mental confusion that are listed in the official product information. These effects may temporarily impact alertness and reaction time, and this safety information is provided for tasks that require high levels of mental focus.


Q: Does Tussilene have known interactions with common antidepressants?

A: Yes. Official documents contain warnings about serious interactions with specific classes of antidepressants. Tussilene must not be taken with MAOIs, and taking it with other serotonergic agents, such as many common SSRI antidepressants, carries a documented risk of Serotonin Syndrome.


Q: Can Tussilene be taken with cold and flu combination medicines?

A: Official safety warnings caution against combining Tussilene with other over-the-counter cold or flu medicines. Many of these combination products already contain dextromethorphan or other ingredients that can increase side effects, raising the risk of accidental overdose or exaggerated effects.


Q: Why is Tussilene often prescribed for night-time coughs?

A: Regulatory documents list drowsiness as a common side effect of Tussilene. The characteristic of drowsiness is generally recognized as beneficial when the medicine is used to suppress a cough that interferes with sleep.


Q: How quickly can a person expect Tussilene to start working?

A: Studies on the drug's action show that Tussilene is generally well-absorbed after it is taken by mouth. Its cough-suppressing action typically begins within 15 to 30 minutes after a dose.


Q: Can Tussilene be taken with common pain relievers like ibuprofen?

A: Official drug interaction databases do not report clinically significant interactions between Tussilene and simple pain relievers like ibuprofen or acetaminophen. Tussilene's primary interaction risks involve other central nervous system-active or serotonergic medicines.


Q: What is the difference between Tussilene and a simple cough drop?

A: Tussilene contains an active ingredient (dextromethorphan) that works systemically in the brain to raise the threshold that triggers the cough reflex. In contrast, a simple cough drop is designed to work locally by providing a soothing effect on the irritated throat.


Q: Is it normal to feel a dry mouth while using Tussilene?

A: While it is not listed among the most common side effects, some safety reports indicate that dry mouth (xerostomia) can occur. It is noted as a less frequent adverse reaction associated with the use of dextromethorphan.


Q: Why is Tussilene only available by prescription in some places?

A: Although it is an over-the-counter (OTC) medicine in many regions, some jurisdictions restrict its sale due to its potential for abuse at high doses. These restrictions typically involve setting age limits or requiring a prescription to purchase the product.


Q: Does Tussilene affect blood pressure?

A: Tussilene is generally not associated with changes in blood pressure when taken at the recommended dose. However, official safety documentation notes that hypertension (high blood pressure) is a potential symptom associated with a serious drug interaction, such as Serotonin Syndrome, or an overdose.


Q: Is Tussilene safe for people who have certain heart conditions?

A: Official regulatory documents do not list Tussilene as a contraindication for use in patients with established heart conditions. However, many combination cough and cold products contain decongestants, which can affect heart rate and blood pressure, making Tussilene monotherapy a primary option for people concerned about these effects.


Q: Are there known issues with Tussilene and certain herbal supplements?

A: Yes. Tussilene may interact with herbal products that have sedating or serotonergic effects. For instance, herbal supplements known to act as CNS depressants (like Valerian Root) or those with serotonergic activity (like St. John's Wort) may increase the risk of side effects or serious interactions.


Q: Does Tussilene show up on standard drug tests?

A: Dextromethorphan or its metabolite, dextrorphan, can be detected in urine for approximately one to two days after use, depending on the dose taken and how fast the individual metabolizes the medicine. Specific toxicology panels may test for its presence.


Q: Is Tussilene used to treat symptoms other than cough?

A: Tussilene is officially regulated and approved only as an antitussive for the temporary relief of cough symptoms. Any other reported uses are outside the scope of its regulatory indication and are not supported by official labeling.


Q: What should I do if I think I've taken too much Tussilene?

A: Official guidance states that in the event of an overdose, contact with the Poison Control Helpline is required. If the individual has collapsed, has had a seizure, or has severe trouble breathing, emergency services should be called without delay.


Q: Does Tussilene cause headaches?

A: Official reports indicate that headache is reported as a less common adverse reaction. While it is not one of the most frequently reported common side effects, it is associated with the use of dextromethorphan.


Q: Does Tussilene contain sugar or artificial sweeteners?

A: Many oral liquid formulations of Tussilene do contain sugar or artificial sweeteners for palatability. For patients monitoring sugar intake, it is important to review the inactive ingredients list, and sugar-free formulations may be available.


Q: Can Tussilene cause blurred vision?

A: Safety data indicates that blurred vision is a potential effect. This is particularly noted as a symptom associated with taking high doses or as a sign of an acute overdose.

Advertisements

How should Tussilene be stored and disposed of?

How to Store and Dispose of Tussilene?

Tussilene (Dextromethorphan Hydrobromide) must be stored strictly according to regulatory labeling to maintain its stability.

Storage Requirements

Condition Official Requirement
Temperature Store at Controlled Room Temperature, between 20 C and 25 C (68 F and 77 F). Do not refrigerate.
Protection Keep in the original, tightly closed container. Protect from excessive heat, light, and moisture.
Child Safety Mandatory to store the product out of the sight and reach of children and to use safety caps.

Disposal

Official instructions for disposal recommend discarding unused or expired Tussilene in the household trash after mixing it with an undesirable substance (like coffee grounds or kitty litter) and placing it in a sealed bag. The medicine must not be flushed down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tussilene found in:

A-Z Index: